Matthew Staron, Ph.D. has extensive experience in the field of immunology and pharmacology. Matthew currently works as a Principal Scientist II at AbbVie, focusing on gastrointestinal diseases and antibody drug conjugates in immunology. Prior to AbbVie, Matthew was a Senior Scientist in Discovery Immunology. Matthew completed their Doctor of Philosophy in Immunology at the University of Connecticut School of Medicine and holds a B.S. in Molecular Cell Biology from the University of Connecticut.
July 1, 2024 - present
November, 2021
June, 2019
March, 2015